Human skin fibroblasts in culture have provided an important and useful tool for studies designed to detect aberrations of connective tissue in diseases. In continuation of this project, we propose extensive studies on the structure and metabolism of collagen and its biosynthetic precursor, procollagen, utilizing human skin fibroblast cultures. The overall goal of these studies is to define the molecular defects which may occur in collagen in acquired and heritable diseases. The main emphasis of these studies will be on two distinct entities, the fibrotic skin diseases and the Ehlers-Danlos syndrome. Cells from these patients will be subjected to in-depth analyses using a variety of techniques, with emphasis on recombinant DNA technology. In case of fibrotic skin diseases, we will examine alterations in collagen gene expression at translational and transcriptional level. Specifically, we will a) determine the steady-state levels of genetically distinct procollagen mRNAs; b) elucidate the transcriptional mechanisms leading to altered mRNA abundance; c) examine the relationship between the gene expression and the state of the gene by assay of DNase hypersensitivity and the methylation of the gene; d) determine the procollagen gene copy number as an indication of gene amplification. In case of the Ehlers-Danlos syndrome we attempt to define structural mutations in collagen by a) examination of type I and type III procollagen mRNAs by Northern blot and dot blot hybridizations; b) detection of mutated sequences by S1-nuclease digestion of mRNA-cDNA hybrids; c) examination of genomic DNA by restriction enzyme mapping; d) detection of single-base substitutions in total genomic DNA by denaturing gradient gel electrophoresis; e) linkage analyses utilizing restriction fragment length polymorphism of the procollagen genes. These studies are expected to yield precise information on the underlying molecular mechanisms of diseases affecting connective tissues. Such data will help us to define the normal structure-function relationships of genetically distinct collagens in skin and other tissues, as it pertains to specific domains and amino acid sequences in the protein. The results will also provide us with knowledge highly useful for the development of rationale treatment modalities for these conditions.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM028833-09
Application #
3276153
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1987-01-01
Project End
1991-07-31
Budget Start
1987-08-01
Budget End
1988-07-31
Support Year
9
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Sollberg, S; Peltonen, J; Uitto, J et al. (1992) Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset. Arthritis Rheum 35:290-8
Uitto, J; Varga, J; Peltonen, J et al. (1992) Eosinophilia-myalgia syndrome. Int J Dermatol 31:223-8
Choi, A M; Olsen, D R; Cook, K G et al. (1992) Differential extracellular matrix gene expression by fibroblasts during their proliferative life span in vitro and at senescence. J Cell Physiol 151:147-55
Muona, P; Peltonen, J; Jaakkola, S et al. (1991) Increased matrix gene expression by glucose in rat neural connective tissue cells in culture. Diabetes 40:605-11
Kahari, V M; Peltonen, J; Chen, Y Q et al. (1991) Differential modulation of basement membrane gene expression in human fibrosarcoma HT-1080 cells by transforming growth factor-beta 1. Enhanced type IV collagen and fibronectin gene expression correlates with altered culture phenotype of the cells. Lab Invest 64:807-18
Peltonen, J; Varga, J; Sollberg, S et al. (1991) Elevated expression of the genes for transforming growth factor-beta 1 and type VI collagen in diffuse fasciitis associated with the eosinophilia-myalgia syndrome. J Invest Dermatol 96:20-5
Uitto, J (1991) Molecular pathology of collagen in cutaneous diseases. Adv Dermatol 6:265-86;discussion 287
Sollberg, S; Peltonen, J; Uitto, J (1991) Combined use of in situ hybridization and unlabeled antibody peroxidase anti-peroxidase methods: simultaneous detection of type I procollagen mRNAs and factor VIII-related antigen epitopes in keloid tissue. Lab Invest 64:125-9
Peltonen, J; Jaakkola, S; Uitto, J (1991) In situ hybridization and immunodetection techniques for simultaneous localization of messenger RNAs and protein epitopes in tissue sections and cultured cells. Methods Enzymol 203:476-84
Kahari, V M; Larjava, H; Uitto, J (1991) Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in cult J Biol Chem 266:10608-15

Showing the most recent 10 out of 92 publications